Inactive Instrument

News INSTEM

Stocks

INS

GB00B3TQCK30

All News

07-26	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-20	Instem Limited Announces Termination of Director Appointment, Effective April 20, 2026	CI
04-15	Instem Announces Appointment of Szczepan Baran as Chief Scientific Officer	CI
03-19	Instem And U.S. Food And Drug Administration Extend Research Collaboration Agreement	CI
12-02	Instem Unveils New Global Headquarters in Boston, Massachusetts	CI
09/10/25	Instem Announces Enhanced Capabilities of Climb? Software for Non-GLP In Vivo Research	CI
28/07/25	Instem Limited acquired Rockstep Solutions, Inc.	CI
17/07/25	Instem Announces Provantis 12: A Powerful Step Forward in Preclinical Study Management	CI
19/06/25	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
19/05/25	Instem Limited acquired Strong Tower Solutions, Inc.	CI
08/01/25	Instem Introduces Cloud-Hosted Non-Glp Pathology Module for Provantis	CI
27/12/24	Instem plc acquired Trimetra Limited.	CI
05/10/24	Instem Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
17/06/24	Instem and Proscia Partners to Accelerate Preclinical Development with Digital Pathology	CI
25/01/24	Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline	CI
21/11/23	Instem Delists from London Bourse's AIM After Merger with ArchiMed	MT
20/11/23	France's Archimed Completes Acquisition of UK's Instem	MT
20/11/23	Instem plc Announces Board Resignations	CI
20/11/23	ArchiMed SAS agreed completed the acquisition of Instem plc (AIM : INS) from group of sellers.	CI
16/11/23	Instem acquisition by Ichor sanctioned by UK court	AN
16/11/23	Instem : Issue of Equity, PDMR Dealings and Rule 2.9 Announcement	PU
16/11/23	UK Court Clears Archimed’s Takeover of Instem	MT
15/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR
13/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR
10/11/23	Samson Rock Capital LLP - Form 8.3 - Instem Plc	PR